Acadia pharmaceuticals inc

Major-Pharmaceuticals

ACAD


3611 Valley Centre Drive
San Diego , CA 92130

Executive/
Director

Price

  • Last Close
  • $ 16.31
    $ +0.62 3.95 %
    Aug 29, 2024
  • 52-Week High/Low
  • $31.77 - $14.63
  • YTD
  • -47.9%

  • Trading Volume
  • 37,904
  • Market Cap Full
  • $ 2.7B
  • Shares Outstanding
  • 164.2M
    Oct 25, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 2.7% -21.6% 19.2% -25.4% 66.1% -5% -51.7% 3.9% 18.2% -41%
Q2 28.5% 16.1% -18.9% -26.9% -0.9% 4% -5.5% -41.8% 27.3% -0.8%
Q3 -21% -2% 35.1% 24.2% 33.2% 8% -31.9% 16.1% -13% -
Q4 7.8% -9.3% -21.7% -22.2% 17.5% 28.5% 40.3% -2.7% 45.8% -
J F M A M J J A S O N D
2024 -17.3% -10.3% -20.4% -2.1% - - - - - - - -
2023 19.5% 8.7% -9% 13.3% 10.2% 1.9% 22.1% -7.6% -22.9% 8.3% -1.3% 40.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    27%12%-19%4%-46%163%25%-56%-32%97%-48%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.40 0.45 0.72 -0.44 -0.59 -0.57 -0.42 -0.7 -0.27
Q2 0.39 0.63 0.55 -0.51 -0.38 -0.27 -0.27 -0.21 0.01
Q3 0.39 0.61 0.53 -0.5 -0.29 -0.54 -0.09 -0.17 -0.40
Q4 0.45 0.65 0.55 -0.49 -0.34 -0.41 -0.27 -0.26 -
A 1.6 2.3 2.4 -1.9 -1.6 -1.8 -1.1 -1.3 -0.66

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 143.9 155.3 160 161.2 162.2
Jun 124.8 144.2 155.7 160.2 161.4 162.6
Sep 125 144.5 157.7 160.6 161.8 163.7
Dec 125.1 154 159 160.8 161.9 164.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.4 1.4 1 1.8 3
Fixed Asset Turnover 27.2 26.9 27.6 30.8 22.4
Total Asset Turnover 0.9 0.7 0.6 0.4 0.4
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 28 85 57.4 20.6 123.5
Equity multiplier 0.1 - - - -